AETERNUM HEALTH, INC. (AETN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 70K 140K 210K FY23: 20.1K FY24: 65.1K FY25: 203.7K FY23 FY24 FY25

Gross Profit Annual

-50K 0 50K 100K 150K FY23: -33K FY24: -12.7K FY25: 120.1K FY23 FY24 FY25

Operating Income Annual

-600K -400K -200K 0 200K 400K 600K FY23: -552.4K FY24: -430.5K FY25: -269.3K FY23 FY24 FY25

Net Income Annual

-750K -500K -250K 0 250K 500K 750K FY23: -632.9K FY24: -450.3K FY25: -337.1K FY23 FY24 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-300K -200K -100K 0 100K 200K 300K FY23: -267K FY24: -154K FY25: -3K FY23 FY24 FY25

Free Cash Flow Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Shares Outstanding Annual

0 20M 40M 60M FY23: 42.5M FY24: 48.5M FY25: 49M FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.45 -0.30 -0.15 0.00 0.15 0.30 0.45 Q1 '12: -0.07 Q2 '12: -0.11 Q3 '12: -0.08 Q4 '12: -0.07 Q1 '13: -0.06 Q2 '13: -0.04 Q3 '13: -0.04 Q4 '13: -0.04 Q1 '14: -0.04 Q2 '14: -0.03 Q3 '14: 0.01 Q4 '14: 0.01 Q1 '16: -0.02 Q2 '16: -0.03 Q3 '16: -0.02 Q4 '16: -0.01 Q1 '17: -0.01 Q2 '17: 0.00 Q3 '17: 0.00 Q4 '17: -0.01 Q1 '18: -0.01 Q2 '18: -0.01 Q3 '18: -0.02 Q4 '18: -0.02 Q4 '20: 0.00 Q1 '21: 0.00 Q2 '21: 0.00 Q3 '21: -0.04 Q4 '21: -0.05 Q1 '22: -0.35 Q2 '22: -0.35 Q3 '22: -0.30 Q4 '22: -0.30 Q3 '24: 0.00 Q4 '24: -0.01 Q1 '26: -0.01 Q2 '26: 0.02 Q2 '12 Q3 '13 Q4 '14 Q1 '17 Q2 '18 Q2 '21 Q3 '22 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.